[The occurence of genetic trombophilic markers in patients evaluated for infertility]

Ceska Gynekol. 2013 Jan;78(1):73-7.
[Article in Czech]

Abstract

Objective: To assess and compare the frequency of selected gene mutations of thrombophilic markers (FV Leiden, FII prothrombin G20210A and MTHFR C677T) in patients with primary and secondary infertility.

Design: Retrospective study.

Setting: Institute of normal anatomy, Faculty of Medicine and Dentistry, Palacky University Olomouc.

Methods: The study included 92 patients with primary infertility and 89 patients with secondary infertility. Indications for examination of these mutations were following: a positive family or personal history, a positive obstetrical history or a repeated failure of assisted reproduction treatment.

Results: According to our anticipation, women with the secondary infertility were significantly older(p < 0.0005) than those with primary infertility. No mutations of genes of examined thrombophilic markers (FV, FII and MTHFR), either alone or in combination, were found in only 8.7 % patients with primary infertility and in 5.6 % patients with secondary infertility. Significantly higher frequency of factor Leiden(p < 0.02) was observed in women with secondary infertility. There were no significant differences in the frequency of detected mutations of the remaining factors.

Conclusion: Based on our findings we suggest that the assessment of selected gene mutations of thrombophilic markers should be a part of the diagnostic algorithm in patients with positive history for thrombophilic disorders.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Factor V / genetics*
  • Female
  • Genetic Markers
  • Humans
  • Infertility, Female / complications
  • Infertility, Female / genetics*
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Mutation*
  • Prothrombin / genetics*
  • Thrombophilia / complications
  • Thrombophilia / genetics

Substances

  • Genetic Markers
  • factor V Leiden
  • Factor V
  • Prothrombin
  • Methylenetetrahydrofolate Reductase (NADPH2)